Determinants of Measles Vaccine Hesitancy among Sudanese Parents in Khartoum State, Sudan: A Cross-Sectional Study.
PACV
Sudan
measles vaccine
vaccine access
vaccine hesitancy
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
22 Dec 2021
22 Dec 2021
Historique:
received:
04
11
2021
revised:
07
12
2021
accepted:
20
12
2021
entrez:
22
1
2022
pubmed:
23
1
2022
medline:
23
1
2022
Statut:
epublish
Résumé
Determinants of vaccine hesitancy are not yet well understood. This study aims to assess measles vaccine hesitancy and characterize its determinants among Sudanese parents in Omdurman in Khartoum State. A community-based cross-sectional quantitative study was conducted in Khartoum State in February 2019. The Parent Attitudes about Childhood Vaccination (PACV) was used to measure measles vaccine hesitancy. Questions about the sociodemographic characteristics of the family, the perception of the parents about the measles vaccine, and the parental exposure to information were asked. Proportions of vaccine hesitancy and coefficients of linear regression were computed. Five hundred parents were recruited for the study. We found that a significant proportion of participants (about 1 in 5 parents) had hesitations regarding the measles vaccine. Significant predictors of measles vaccine hesitancy were parental exposure to anti-vaccination information or materials (β = -0.478,
Identifiants
pubmed: 35062667
pii: vaccines10010006
doi: 10.3390/vaccines10010006
pmc: PMC8780692
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Vaccine. 2019 Feb 4;37(6):848-856
pubmed: 30642731
Nature. 2021 Jan;589(7842):415-419
pubmed: 33328634
Vaccines (Basel). 2020 Nov 20;8(4):
pubmed: 33233535
BMC Public Health. 2018 May 2;18(1):566
pubmed: 29716556
Hum Vaccin Immunother. 2018;14(10):2355-2357
pubmed: 29617173
Eur J Pediatr. 2019 Feb;178(2):243-251
pubmed: 30430239
Vaccine. 2010 Jun 11;28(26):4235-48
pubmed: 20438879
Z Gesundh Wiss. 2021 Oct 9;:1-10
pubmed: 34660175
Vaccine. 2018 Oct 22;36(44):6473-6479
pubmed: 28811050
PLoS One. 2018 Jan 25;13(1):e0191620
pubmed: 29370258
Am J Prev Med. 2021 Jan;60(1 Suppl 1):S24-S33
pubmed: 33131990
Vaccines (Basel). 2019 Oct 18;7(4):
pubmed: 31635270
Health Care Manag Sci. 2012 Sep;15(3):188-96
pubmed: 22528136
Pan Afr Med J. 2020 Feb 20;35(Suppl 1):15
pubmed: 32373266
Vaccine. 2018 Aug 16;36(34):5141-5149
pubmed: 30026033
Euro Surveill. 2011 Apr 28;16(17):
pubmed: 21543043
Vaccine. 2018 Aug 23;36(35):5273-5281
pubmed: 30061026
Expert Rev Vaccines. 2021 May;20(5):611-621
pubmed: 33682587
Vaccine. 2018 Nov 19;36(48):7294-7299
pubmed: 30340882
Pan Afr Med J. 2019 May 29;33:67
pubmed: 31448029
JAMA Pediatr. 2013 Nov;167(11):1065-71
pubmed: 24061681
Vaccine. 2011 Sep 2;29(38):6598-605
pubmed: 21763384
Vaccine. 2018 Jan 29;36(5):660-667
pubmed: 29289384
Vaccine. 2014 Apr 17;32(19):2150-9
pubmed: 24598724
Vaccine. 2015 Aug 14;33(34):4165-75
pubmed: 25896384
Front Public Health. 2021 Jun 25;9:586333
pubmed: 34249823
PLoS One. 2020 Aug 6;15(8):e0237171
pubmed: 32760162
Vaccines (Basel). 2019 Feb 24;7(1):
pubmed: 30813481
PLoS One. 2012;7(5):e37905
pubmed: 22662247
PLoS One. 2019 Jun 20;14(6):e0213882
pubmed: 31220092
Glob Health Res Policy. 2019 Feb 28;4:5
pubmed: 30859137
Vaccine. 2017 May 19;35(22):2955-2961
pubmed: 28434687
Curr Opin Immunol. 2021 Aug;71:55-61
pubmed: 34087523